CLDX Operating Cash Flow Growth
Celldex Therapeutics Inc · Operating Cash Flow Growth
CLDX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-26.52%period ending
CLDX TTM Cash from Operations YoY % (-163.64% → -26.52%)
Year-over-year change
High-resolution chart · PNG
CLDX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -26.5191% | |
| -29.5309% | |
| -33.6973% | |
| -13.7143% | |
| -53.2542% | |
| -43.693% | |
| -47.0561% | |
| -63.5257% | |
| -7.7822% | |
| -10.7575% | |
| -3.431% | |
| -0.028% | |
| -45.1199% | |
| -59.989% | |
| -70.3065% | |
| -87.0128% | |
| -64.9599% | |
| -45.2391% | |
| -50.7499% | |
| -11.6987% | |
| -3.5494% | |
| -2.3978% | |
| 12.9506% | |
| 9.1494% | |
| 15.9374% | |
| 25.0703% | |
| 38.3066% | |
| 35.9037% | |
| 39.4249% | |
| 34.7876% | |
| 24.7131% | |
| 21.2715% | |
| 11.0151% | |
| 18.259% | |
| 11.5937% | |
| 5.3302% | |
| 8.9917% | |
| -12.0514% | |
| -14.3083% | |
| 0.8607% | |
| -3.8726% | |
| 1.0279% | |
| 2.6099% | |
| -13.8693% | |
| -24.6823% | |
| -24.1754% | |
| -50.0495% | |
| -42.7663% | |
| -43.0285% | |
| -54.1185% | |
| -35.9307% | |
| -44.106% | |
| -38.6274% | |
| -32.4237% | |
| -39.6096% | |
| -41.863% | |
| -34.2494% | |
| -24.9288% | |
| -17.4042% | |
| 8.2301% | |
| 2.961% | |
| -3.3174% | |
| -1.684% | |
| -98.5204% | |
| -55.4378% | |
| -283.4716% | |
| -263.3903% | |
| -236.8917% | |
| -221.9934% | |
| 198.2536% | |
| 194.7043% | |
| 175.1188% | |
| 204.9835% | |
| -6.0215% | |
| -171.4917% | |
| -155.5373% | |
| -154.0098% | |
| -146.577% | |
| 548.7615% | |
| 367.0474% | |
| 395.2347% | |
| 386.958% | |
| 41.8565% | |
| -15.159% | |
| -5.9038% | |
| -13.117% | |
| 11.8532% | |
| -7.5967% | |
| 17.0656% | |
| 24.4964% | |
| 29.5329% | |
| 55.737% | |
| 45.7423% | |
| 31.6588% | |
| 20.0048% | |
| -35.481% | |
| -75.5832% | |
| -92.3704% | |
| -369.9% | |
| -190.6256% |